HomeCompareSNBHD vs MRK

SNBHD vs MRK: Dividend Comparison 2026

SNBHD yields 1503.76% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SNBHD wins by $717986600.86M in total portfolio value
10 years
SNBHD
SNBHD
● Live price
1503.76%
Share price
$0.13
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$717986600.92M
Annual income
$634,928,120,001,842.20
Full SNBHD calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — SNBHD vs MRK

📍 SNBHD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSNBHDMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SNBHD + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SNBHD pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SNBHD
Annual income on $10K today (after 15% tax)
$127,819.55/yr
After 10yr DRIP, annual income (after tax)
$539,688,902,001,565.90/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, SNBHD beats the other by $539,688,901,993,237.44/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SNBHD + MRK for your $10,000?

SNBHD: 50%MRK: 50%
100% MRK50/50100% SNBHD
Portfolio after 10yr
$358993300.49M
Annual income
$317,464,060,005,820.20/yr
Blended yield
88.43%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SNBHD
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SNBHD buys
0
MRK buys
0
No recent congressional trades found for SNBHD or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSNBHDMRK
Forward yield1503.76%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$717986600.92M$56.8K
Annual income after 10y$634,928,120,001,842.20$9,798.13
Total dividends collected$711941410.43M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SNBHD vs MRK ($10,000, DRIP)

YearSNBHD PortfolioSNBHD Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$161,076$150,375.94$11,206$366.19+$149.9KSNBHD
2$2,436,085$2,263,733.26$12,650$502.35+$2.42MSNBHD
3$34,603,160$31,996,549.75$14,407$694.19+$34.59MSNBHD
4$461,784,572$424,759,190.72$16,585$967.82+$461.77MSNBHD
5$5,791,752,185$5,297,642,692.55$19,342$1,363.89+$5791.73MSNBHD
6$68,294,005,855$62,096,831,017.85$22,913$1,947.19+$68293.98MSNBHD
7$757,393,078,522$684,318,492,256.79$27,662$2,823.89+$757393.05MSNBHD
8$7,903,137,573,791$7,092,726,979,772.09$34,159$4,173.35+$7903137.54MSNBHD
9$77,624,748,520,893$69,168,391,316,936.66$43,337$6,308.80+$77624748.48MSNBHD
10$717,986,600,919,198$634,928,120,001,842.20$56,776$9,798.13+$717986600.86MSNBHD

SNBHD vs MRK: Complete Analysis 2026

SNBHDStock

Sentient Brands Holdings Inc., a product development and brand management company, builds brands in the luxury and premium market space in the United States. The company offers Oeuvre, a luxury skin care line and lifestyle brand comprising purifying exfoliator, replenishing facial oil, ultra-nourishing face cream, and revitalizing eye cream products. It sells its products through direct-to-consumer e-commerce platforms and wholesale partners. The company was formerly known as Intelligent Buying, Inc. and changed its name to Sentient Brands Holdings Inc. in March 2021. Sentient Brands Holdings Inc. was founded in 2002 and is based in New York, New York.

Full SNBHD Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this SNBHD vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SNBHD vs SCHDSNBHD vs JEPISNBHD vs OSNBHD vs KOSNBHD vs MAINSNBHD vs JNJSNBHD vs ABBVSNBHD vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.